The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Psoriatic Arthritis Drugs Market Research Report 2025
Synopsis
The global Psoriatic Arthritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs.
Report Scope
The Psoriatic Arthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Segment by Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psoriatic Arthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Psoriatic Arthritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs.
Report Scope
The Psoriatic Arthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Psoriatic Arthritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Segment by Application
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Psoriatic Arthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Psoriatic Arthritis Drugs Market Overview
1.1 Product Overview and Scope of Psoriatic Arthritis Drugs
1.2 Psoriatic Arthritis Drugs Segment by Type
1.2.1 Global Psoriatic Arthritis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Other
1.3 Psoriatic Arthritis Drugs Segment by Application
1.3.1 Global Psoriatic Arthritis Drugs Market Value by Application: (2024-2030)
1.3.2 Mild Psoriatic Arthritis
1.3.3 Moderate Psoriatic Arthritis
1.3.4 Severe Psoriatic Arthritis
1.4 Global Psoriatic Arthritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Psoriatic Arthritis Drugs Revenue 2019-2030
1.4.2 Global Psoriatic Arthritis Drugs Sales 2019-2030
1.4.3 Global Psoriatic Arthritis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Psoriatic Arthritis Drugs Market Competition by Manufacturers
2.1 Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Psoriatic Arthritis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Psoriatic Arthritis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriatic Arthritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriatic Arthritis Drugs, Product Type & Application
2.7 Psoriatic Arthritis Drugs Market Competitive Situation and Trends
2.7.1 Psoriatic Arthritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Psoriatic Arthritis Drugs Players Market Share by Revenue
2.7.3 Global Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Psoriatic Arthritis Drugs Retrospective Market Scenario by Region
3.1 Global Psoriatic Arthritis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Psoriatic Arthritis Drugs Global Psoriatic Arthritis Drugs Sales by Region: 2019-2030
3.2.1 Global Psoriatic Arthritis Drugs Sales by Region: 2019-2024
3.2.2 Global Psoriatic Arthritis Drugs Sales by Region: 2025-2030
3.3 Global Psoriatic Arthritis Drugs Global Psoriatic Arthritis Drugs Revenue by Region: 2019-2030
3.3.1 Global Psoriatic Arthritis Drugs Revenue by Region: 2019-2024
3.3.2 Global Psoriatic Arthritis Drugs Revenue by Region: 2025-2030
3.4 North America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.4.1 North America Psoriatic Arthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Psoriatic Arthritis Drugs Sales by Country (2019-2030)
3.4.3 North America Psoriatic Arthritis Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.5.1 Europe Psoriatic Arthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Psoriatic Arthritis Drugs Sales by Country (2019-2030)
3.5.3 Europe Psoriatic Arthritis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Psoriatic Arthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Psoriatic Arthritis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Psoriatic Arthritis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Psoriatic Arthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Psoriatic Arthritis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Psoriatic Arthritis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriatic Arthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psoriatic Arthritis Drugs Sales by Type (2019-2030)
4.1.1 Global Psoriatic Arthritis Drugs Sales by Type (2019-2024)
4.1.2 Global Psoriatic Arthritis Drugs Sales by Type (2025-2030)
4.1.3 Global Psoriatic Arthritis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Psoriatic Arthritis Drugs Revenue by Type (2019-2030)
4.2.1 Global Psoriatic Arthritis Drugs Revenue by Type (2019-2024)
4.2.2 Global Psoriatic Arthritis Drugs Revenue by Type (2025-2030)
4.2.3 Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Psoriatic Arthritis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Psoriatic Arthritis Drugs Sales by Application (2019-2030)
5.1.1 Global Psoriatic Arthritis Drugs Sales by Application (2019-2024)
5.1.2 Global Psoriatic Arthritis Drugs Sales by Application (2025-2030)
5.1.3 Global Psoriatic Arthritis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Psoriatic Arthritis Drugs Revenue by Application (2019-2030)
5.2.1 Global Psoriatic Arthritis Drugs Revenue by Application (2019-2024)
5.2.2 Global Psoriatic Arthritis Drugs Revenue by Application (2025-2030)
5.2.3 Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Psoriatic Arthritis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbvie
6.1.1 Abbvie Corporation Information
6.1.2 Abbvie Description and Business Overview
6.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbvie Psoriatic Arthritis Drugs Product Portfolio
6.1.5 Abbvie Recent Developments/Updates
6.2 Janssen
6.2.1 Janssen Corporation Information
6.2.2 Janssen Description and Business Overview
6.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Psoriatic Arthritis Drugs Product Portfolio
6.2.5 Janssen Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Corporation Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amgen Psoriatic Arthritis Drugs Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Psoriatic Arthritis Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Eli-Lilly
6.5.1 Eli-Lilly Corporation Information
6.5.2 Eli-Lilly Description and Business Overview
6.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli-Lilly Psoriatic Arthritis Drugs Product Portfolio
6.5.5 Eli-Lilly Recent Developments/Updates
6.6 Celgene
6.6.1 Celgene Corporation Information
6.6.2 Celgene Description and Business Overview
6.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Celgene Psoriatic Arthritis Drugs Product Portfolio
6.6.5 Celgene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriatic Arthritis Drugs Industry Chain Analysis
7.2 Psoriatic Arthritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriatic Arthritis Drugs Production Mode & Process
7.4 Psoriatic Arthritis Drugs Sales and Marketing
7.4.1 Psoriatic Arthritis Drugs Sales Channels
7.4.2 Psoriatic Arthritis Drugs Distributors
7.5 Psoriatic Arthritis Drugs Customers
8 Psoriatic Arthritis Drugs Market Dynamics
8.1 Psoriatic Arthritis Drugs Industry Trends
8.2 Psoriatic Arthritis Drugs Market Drivers
8.3 Psoriatic Arthritis Drugs Market Challenges
8.4 Psoriatic Arthritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
